Search Results 501-510 of 16754 for Proliferation
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency ( ...
To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular ...
About this study. The purpose of this study is to determine if patients treated with long term maintenance medical therapies have a lowered risk of needing ...
The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...
Zaidan A, Bruce KH, Hopkins MR, Robinson SI, Rose CH, VanBuren WM, Langstraat CL. Active surveillance of an endometriosis-related, hormone-responsive pelvic ...
Rochester, Minn. The primary purpose of this study is to assess and describe the contributing sources of discomfort(s) experienced by ICU patients utilizing the ...
This randomized clinical trial studies the intensity of adjuvant ("helper") therapy required in p16 positive oropharynx cancer patients, who have had all known ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.